Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Vox Sanguinis|January 1, 1989
Hemophilia: state of the art of hematologic care 1988C K Kasper, J B Graham, P B Kernoff, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 8, 2002
Continuous infusion of porcine factor VIII: stability, microbiological safety and clinical experienceD M DiMichele, P O Gorman, C K Kasper, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 24, 1999
Haemophilia B Brandenberg-type promoter mutationJ A Heit, R P Ketterling, R E Zapata, et al.
The Journal of Biological Chemistry|February 15, 1990
Experimental and theoretical evidence supporting the role of Gly363 in blood coagulation factor IXa (Gly193 in chymotrypsin) for proper activation of the proenzymeS P Bajaj, S G Spitzer, W J Welsh, et al.
Genomics|January 1, 1990
Characterization of mutations in the factor VIII gene by direct sequencing of amplified genomic DNAM Higuchi, C Wong, L Kochhan, et al.
The Journal of Physical Chemistry. B|October 26, 2012
Multi-scale simulation of the simian immunodeficiency virus fusion peptideJean-Marc Crowet, Daniel L Parton, Benjamin A Hall, et al.
JAMA|March 16, 1984
Nontransmission of T-cell subset abnormalities from hemophiliacs to their spousesJ K Kreiss, C K Kasper, J L Fahey, et al.
Vox Sanguinis|January 1, 1994
Hepatitis A virus transmission by blood products in the United States. Transfusion Safety Study GroupJ W Mosley, M J Nowicki, C K Kasper, et al.
Structure (London, England : 1993)|February 24, 2015
Nothing to sneeze at: a dynamic and integrative computational model of an influenza A virionTyler Reddy, David Shorthouse, Daniel L Parton, et al.
Thrombosis and Haemostasis|March 2, 1992
Production and therapeutic use of a factor XI concentrate from plasmaP H Bolton-Maggs, R T Wensley, P B Kernoff, et al.
Pageof 12